Newsletter
Connecting people, advancing clinical value
This is Vol.71 Newsletter for January 2026. This issue covers the global pharmaceutical market’s shift toward metabolic diseases from 2026 and the post-GLP-1 competitive landscape, intensifying...
This is 70 Newsletter for December 2025. This article we focus at the growing gap between how much global pharma is investing in Korean R&D and how little Korean patients still access new...
This is 69 Newsletter for November 2025. This article we focus at the growing gap between how much global pharma is investing in Korean R&D and how little Korean patients still access new...
